10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
MERCK & CO., INC. | |||
Ticker: MRK Fiscal Year: 2017 | |||
Consolidated Statement of Income | |||
Period Ending Dec 31, 2017 10-K (Filed: Feb 27, 2018) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | |
| Sales | $ 40,122 | 39,807 | 39,498 |
| Costs, Expenses and Other | |||
| Materials and production | 12,775 | 13,891 | 14,934 |
| Marketing and administrative | 9,830 | 9,762 | 10,313 |
| Research and development | 10,208 | 10,124 | 6,704 |
| Restructuring costs | 776 | 651 | 619 |
| Other (income) expense, net | 12 | 720 | 1,527 |
| Total Costs, Expenses and Other | 33,601 | 35,148 | 34,097 |
| Income Before Taxes | 6,521 | 4,659 | 5,401 |
| Taxes on Income | 4,103 | 718 | 942 |
| Net Income | 2,418 | 3,941 | 4,459 |
| Less: Net Income Attributable to Noncontrolling Interests | 24 | 21 | 17 |
| Net Income Attributable to Merck & Co., Inc. | 2,394 | 3,920 | 4,442 |
| Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share) | 0.88 | 1.42 | 1.58 |
| Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share) | 0.87 | 1.41 | 1.56 |
| External Links | |
| MERCK & CO., INC. (MRK) Fiscal Year 2017 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |